JP2021130676A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021130676A5 JP2021130676A5 JP2021085852A JP2021085852A JP2021130676A5 JP 2021130676 A5 JP2021130676 A5 JP 2021130676A5 JP 2021085852 A JP2021085852 A JP 2021085852A JP 2021085852 A JP2021085852 A JP 2021085852A JP 2021130676 A5 JP2021130676 A5 JP 2021130676A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- antigen recognition
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023070426A JP2023093656A (ja) | 2015-08-11 | 2023-04-21 | 抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015159240 | 2015-08-11 | ||
| JP2015159240 | 2015-08-11 | ||
| JP2019101116A JP2019201641A (ja) | 2015-08-11 | 2019-05-30 | 抗体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019101116A Division JP2019201641A (ja) | 2015-08-11 | 2019-05-30 | 抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023070426A Division JP2023093656A (ja) | 2015-08-11 | 2023-04-21 | 抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021130676A JP2021130676A (ja) | 2021-09-09 |
| JP2021130676A5 true JP2021130676A5 (enExample) | 2022-04-27 |
Family
ID=57983824
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017534378A Active JP6548052B2 (ja) | 2015-08-11 | 2016-08-02 | 抗体 |
| JP2019101116A Withdrawn JP2019201641A (ja) | 2015-08-11 | 2019-05-30 | 抗体 |
| JP2021085852A Pending JP2021130676A (ja) | 2015-08-11 | 2021-05-21 | 抗体 |
| JP2023070426A Pending JP2023093656A (ja) | 2015-08-11 | 2023-04-21 | 抗体 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017534378A Active JP6548052B2 (ja) | 2015-08-11 | 2016-08-02 | 抗体 |
| JP2019101116A Withdrawn JP2019201641A (ja) | 2015-08-11 | 2019-05-30 | 抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023070426A Pending JP2023093656A (ja) | 2015-08-11 | 2023-04-21 | 抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US10654931B2 (enExample) |
| EP (1) | EP3336184A4 (enExample) |
| JP (4) | JP6548052B2 (enExample) |
| KR (2) | KR102713140B1 (enExample) |
| CN (2) | CN107922938B (enExample) |
| AU (3) | AU2016306320B2 (enExample) |
| CA (1) | CA2995046A1 (enExample) |
| HK (1) | HK1249549A1 (enExample) |
| IL (2) | IL257368B2 (enExample) |
| MX (2) | MX2018001668A (enExample) |
| PH (1) | PH12018500258B1 (enExample) |
| SG (2) | SG11201800864XA (enExample) |
| WO (1) | WO2017026331A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1249549A1 (en) * | 2015-08-11 | 2018-11-02 | Osaka University | Antibody |
| US11744862B2 (en) * | 2017-03-20 | 2023-09-05 | City Of Hope | CS1 targeted chimeric antigen receptor-modified T cells for treatment of AL amyloidosis |
| CN110577605A (zh) * | 2018-06-11 | 2019-12-17 | 浙江启新生物技术有限公司 | 一种靶向多发性骨髓瘤多种抗原的嵌合抗原受体t（car-t）细胞的构建方法及其应用 |
| JPWO2023013765A1 (enExample) * | 2021-08-06 | 2023-02-09 | ||
| KR20240051172A (ko) | 2021-08-20 | 2024-04-19 | 오츠카 세이야쿠 가부시키가이샤 | 조합 의약 |
| WO2024249568A1 (en) | 2023-05-30 | 2024-12-05 | Paragon Therapeutics, Inc. | Alpha4beta7 integrin antibody compositions and methods of use |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3180125B2 (ja) * | 1992-03-07 | 2001-06-25 | 道生 河野 | ヒト成熟骨髄腫細胞に対するモノクローナル抗体 |
| JPH06303990A (ja) * | 1993-04-24 | 1994-11-01 | Kanebo Ltd | モノクローナル抗体、それを産生するハイブリドーマおよび該抗体の製造方法 |
| MX9710010A (es) * | 1996-04-15 | 1998-03-29 | Icos Corp | Modulares citoplasmicos de regulacion/transmision de señales de integrina. |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| US6376654B1 (en) * | 1999-08-13 | 2002-04-23 | Molecular Discoveries, Llc | Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| US7803376B2 (en) * | 2003-07-24 | 2010-09-28 | Innate Pharma S.A. | Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
| AU2003286499A1 (en) * | 2003-10-17 | 2004-06-06 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Interference with c-maf function in multiple myeloma |
| BRPI0710826A2 (pt) | 2006-04-21 | 2011-08-23 | Novartis Ag | composições farmacêuticas de anticorpo anti-cd40 antagonista |
| NZ590605A (en) | 2008-07-09 | 2012-11-30 | Biogen Idec Inc | Compositions comprising antibodies to lingo or fragments thereof |
| CN102388068B (zh) * | 2009-03-20 | 2015-05-20 | 安姆根有限公司 | α-4-β-7异二聚体特异性拮抗剂抗体 |
| WO2010117059A1 (ja) | 2009-04-10 | 2010-10-14 | 国立大学法人大阪大学 | 形質細胞の腫瘍性増殖をきたす疾患の治療薬 |
| WO2012022634A1 (en) * | 2010-08-16 | 2012-02-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Classification, diagnosis and prognosis of multiple myeloma |
| UA116189C2 (uk) * | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| EP2814846B1 (en) | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| CN103374073A (zh) * | 2012-04-26 | 2013-10-30 | 中国科学院上海生命科学研究院 | 识别活化形式整合素α4β7的人源化单克隆抗体 |
| EP3495814A3 (en) * | 2013-03-27 | 2019-07-17 | F. Hoffmann-La Roche AG | Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists |
| BR112016001611B1 (pt) * | 2013-07-25 | 2024-01-09 | Cytomx Therapeutics, Inc | Anticorpo ativável multiespecífico, uso terapêutico do mesmo, molécula de ácido nucleico isolada, vetor e método para produzir um anticorpo ativável multiespecífico |
| HK1249549A1 (en) * | 2015-08-11 | 2018-11-02 | Osaka University | Antibody |
-
2016
- 2016-08-02 HK HK18109155.2A patent/HK1249549A1/en unknown
- 2016-08-02 KR KR1020187006417A patent/KR102713140B1/ko active Active
- 2016-08-02 MX MX2018001668A patent/MX2018001668A/es unknown
- 2016-08-02 CN CN201680046842.8A patent/CN107922938B/zh active Active
- 2016-08-02 IL IL257368A patent/IL257368B2/en unknown
- 2016-08-02 WO PCT/JP2016/072688 patent/WO2017026331A1/ja not_active Ceased
- 2016-08-02 AU AU2016306320A patent/AU2016306320B2/en active Active
- 2016-08-02 EP EP16835028.8A patent/EP3336184A4/en active Pending
- 2016-08-02 CA CA2995046A patent/CA2995046A1/en active Pending
- 2016-08-02 SG SG11201800864XA patent/SG11201800864XA/en unknown
- 2016-08-02 SG SG10201913748QA patent/SG10201913748QA/en unknown
- 2016-08-02 CN CN202111106559.9A patent/CN113893341B/zh active Active
- 2016-08-02 JP JP2017534378A patent/JP6548052B2/ja active Active
- 2016-08-02 IL IL301753A patent/IL301753A/en unknown
- 2016-08-02 PH PH1/2018/500258A patent/PH12018500258B1/en unknown
- 2016-08-02 KR KR1020247032436A patent/KR20240149974A/ko not_active Ceased
- 2016-08-02 US US15/751,574 patent/US10654931B2/en active Active
-
2018
- 2018-02-08 MX MX2022013566A patent/MX2022013566A/es unknown
-
2019
- 2019-05-30 JP JP2019101116A patent/JP2019201641A/ja not_active Withdrawn
-
2020
- 2020-03-04 US US16/808,451 patent/US20200283533A1/en not_active Abandoned
- 2020-06-18 US US16/905,211 patent/US10988540B2/en active Active
-
2021
- 2021-03-22 US US17/208,014 patent/US20220041735A1/en not_active Abandoned
- 2021-05-21 JP JP2021085852A patent/JP2021130676A/ja active Pending
-
2022
- 2022-07-04 AU AU2022204792A patent/AU2022204792B2/en active Active
-
2023
- 2023-04-21 JP JP2023070426A patent/JP2023093656A/ja active Pending
-
2024
- 2024-05-13 US US18/662,493 patent/US20240360222A1/en active Pending
-
2025
- 2025-08-06 AU AU2025213596A patent/AU2025213596A1/en active Pending